top of page

GPCR News Powered by our Strategic Partners

Post: Blog2_Post

Search

Episode 86 of the Dr. GPCR podcast with Dr. Nicole (Nicki) Perry-Hauser is now available!

Dr. GPCR News
Sep 9, 2022
1 min read

Episode 86 of the Dr. GPCR podcast with Dr. Nicole (Nicki) Perry-Hauser is now available

What a fun chat!

📹Would you like to see the video? Subscribe to a Dr. GPCR Ecosystem paid membership to enjoy everything Dr. GPCR has!

➡️https://bit.ly/3TCJVQQ

ree

Recent Posts

Binding Beyond Clearance

Beyond Clearance: The Strategic Power of Irreversible Drug Binding

Most scientists are taught to aim for precision and control. But what if that mindset blocks the very breakthroughs we seek? Dr. Eric Trinquet, a veteran innovator behind functional GPCR assays like HTRF and IP-One, believes rigid thinking is the enemy of discovery. In this podcast, he lays out the mindset that helped shape products used across biotech and academia—and why play, failure, and surprise are not risks to manage, but fuel to harness.

How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs

Every drug you design will meet an enzyme before it meets its receptor. If you want your molecules to survive first contact with biology, enzyme inhibition must be part of your core playbook.

Understanding Enzyme Inhibition In GPCR Discovery Programs

Comments

bottom of page